ArticleEmerging infectious diseases2020
Global Expansion of Pacific Northwest Vibrio parahaemolyticus Sequence Type 36.
Article in Emerging infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Emergent Vibrio parahaemolyticus Gastroenteritis Outbreaks, New Zealand, 2019-2022.Emerging infectious diseases · 2026Article
- Proteomic adaptation of the hypervirulent pandemicFrontiers in microbiology · 2026Article
- Climate change andProceedings of the National Academy of Sciences of the United States of America · 2025Article
- Prevalence and Genomic Characterization ofFoods (Basel, Switzerland) · 2025Article
- MtlA gene sequencing based on 3rd -generation sequencing for Vibrio typing.BMC microbiology · 2025Article
- Recent Discovery of Diverse Prophages Located in Genomes ofFoods (Basel, Switzerland) · 2025Review
- Prevalence and virulence of Vibrio parahaemolyticus isolated from clinical and environmental samples in Huzhou, China.BMC genomics · 2024Article
- Eco-Evolutionary Drivers of Vibrio parahaemolyticus Sequence Type 3 Expansion: Retrospective Machine Learning Approach.JMIR bioinformatics and biotechnology · 2024Article
- Identifying gene-level mechanisms of successful dispersal ofMicrobial genomics · 2024Article
- Complete genome sequence ofMicrobiology resource announcements · 2024Article
- Public health aspects ofEFSA journal. European Food Safety Authority · 2024Article
- Article
- gcPathogen: a comprehensive genomic resource of human pathogens for public health.Nucleic acids research · 2024Article
- First report of Acinetobacter pittii acute community-acquired pneumonia in an immunocompetent patient in France following a heat wave.BMC infectious diseases · 2024Article
- Microbial threats and sustainable solutions for molluscan aquaculture.Sustainable microbiology · 2024Review
- Predator-Prey Interactions betweenMicrobiology spectrum · 2023Article
- Comparative genomics uncovered differences between clinical and environmental populations ofMicrobial genomics · 2023Article
- What Whole Genome Sequencing Has Told Us About Pathogenic Vibrios.Advances in experimental medicine and biology · 2023Review
- Growth Rates of Vibrio parahaemolyticus Sequence Type 36 Strains in Live Oysters and in Culture Medium.Microbiology spectrum · 2022Article
- Infectious disease in an era of global change.Nature reviews. Microbiology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report transcontinental expansion of Vibrio parahaemolyticus sequence type 36 into Lima, Peru. From national collections, we identified 7 isolates from 2 different Pacific Northwest complex lineages that surfaced during 2011-2016. Sequence type 36 is likely established in environmental reservoirs. Systematic surveillance enabled detection of these epidemic isolates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.